News
Lilly has been chasing—and gaining on—its chief metabolic medicine rival Novo Nordisk and its counterpart GLP-1s Ozempic and ...
US President Donald Trump recently announced tariffs as high as 100% on certain semiconductor products. Although South Korea ...
According to estimates by the Federation of Indian Export Organisations, about 55 per cent of exports to the US will be ...
As investors and industry watchers juggle the twin possibilities of pharmaceutical import tariffs and potential drug pricing ...
Prior to Trump's tariffs, Canadian exporters could trade with the U.S. under Most Favoured Nation (MFN) status. That allowed them to trade with very low tariffs — or none at all — without registering ...
In response, African countries must pursue smart sector-specific bilateral deals and push for tariff exemptions on key ...
4h
Kathmandu Post (EKantipur.com) on MSNRavindra Dhat shines on International MMA StageThe Bajhang-born fighter, who refused an offer to represent India, has become Nepal’s first international MMA champion after his victory at Matrix Fight Night in Noida.
At the halfway point of the resumed fifth session of the Intergovernmental Negotiating Committee (INC-5.2) in Geneva to deve ...
The Trump Administration is pursuing decidedly anti-growth policies. The results will be a weaker economy that violates his ...
Aside from the MFN order, President Trump is also in the process of negotiating tariffs with countries all over the world. It ...
German drugmaker Merck KGaA on Thursday joined peers in saying it was considering distribution models that serve U.S.
It’s a bad time to try to predict future pharmaceutical prices.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results